ArticleBasic & clinical pharmacology & toxicology2021
The tyrosine kinase inhibitor nilotinib inhibits SARS-CoV-2 in vitro.
Valeria Cagno et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it